Cancer is a very dangerous disease that affects many humans worldwide. It is dangerous due to the fact that it can affect many different tissues and organs in the human with most types of cancer untreatable. One certain type of cancer that is very dangerous is called multiple myeloma. This cancer is in the blood and it affects the white blood cells or the plasma in the body. This type of cancer can lead to fatality of not found in an early stage.
A new study conducted by a team of scientists, led by PhD holder Lawrence Boise who is a professor and vice chair for basic research in the Department of Hematology and Medical Oncology at Winship Cancer Institute and Emory University School of Medicine was focusing on DNA related to the disease. According to their findings, DNA markers can predict the outcome of multiple myeloma in the body; in terms of negative effects.
This marker was done by rearranging chromosomes, finding results suggesting that they are resistant to the cancer treatment. The study was published in the journal of Nature Communications.
Dr. Boise commented on his results saying, “This could be different than other markers that we currently use in myeloma, because it may influence which drugs physicians may choose in both initial treatments as well as maintenance therapy. This work is a perfect example of the benefits of broad access to CoMMPass data.”
The co-author of the study was an internationally recognized authority on multiple myeloma, Sagar Lonial.